Chancellor’s Spring Statement/ Budget

The UK Chancellor’s Spring Statement yesterday did not herald changes to duties on alcohol, tobacco or drugs. There do not seem to be public-health grant cuts to local authorities, which commission alcohol/drug services. But access and demand might be affected by cuts to Personal Independence Payments and Universal Credit health elements. Read more...

The welfare adjustments announced in the UK Chancellor’s Spring Statement 2025, delivered by Rachel Reeves on March 26, 2025, do not directly target funding or provision for alcohol or drug treatment services. However, they could indirectly influence access to and demand for such services due to broader changes in welfare spending and benefits eligibility. Here’s how this breaks down:
The Spring Statement 2025 focused heavily on reforming the welfare system, particularly disability and incapacity benefits, with an aim to reduce expenditure and encourage employment. Key measures include cuts to Personal Independence Payments (PIP) and Universal Credit health elements, affecting an estimated 3.2 million families by 2030 with an average loss of £1,720 annually, while 3.8 million families gain a smaller average increase of £420 per year. These adjustments are part of a strategy to address a projected £18 billion rise in welfare costs by 2029/30, driven by increasing claims for disability and health-related benefits.
Alcohol and drug treatment services in the UK are primarily funded through the public health grant to local authorities, supplemented by additional ringfenced funding from the Department of Health and Social Care (DHSC) under the government’s 10-year Drug Strategy (launched in 2021). For 2024/25, this additional funding totals £266.7 million, building on prior allocations (e.g., £532 million committed from 2022-2025). The Spring Statement 2025 documents and related commentary do not indicate any cuts or changes to this specific funding stream. Day-to-day public spending, which includes health budgets, is set to rise by 1.2% annually above inflation, suggesting no immediate reduction in public health resources that support treatment services.
However, the welfare cuts could indirectly impact alcohol and drug treatment in several ways:
  1. Increased Vulnerability: Reduced benefits, particularly for those with health conditions or disabilities, might exacerbate financial stress among individuals already struggling with substance misuse. Problematic alcohol or drug use is often linked to mental health issues and economic hardship—conditions that could worsen if disposable income drops. This might increase demand for treatment services, straining existing capacity, especially if funding remains static.
  2. Eligibility and Access: Some individuals receiving PIP or Universal Credit health elements may have been using these funds to supplement access to private or discretionary support services (e.g., counseling or rehab not fully covered by public provision). A reduction in these payments could limit their ability to seek such help, pushing more reliance onto NHS and local authority services, which are already under pressure. The government’s “Pathways to Work” Green Paper, referenced in the statement, aims to shift focus to early intervention and employment, but it doesn’t specify enhanced support for substance misuse treatment.
  3. Economic Inactivity Link: The statement highlights tackling economic inactivity, with Reeves noting that “too many people are trapped on out-of-work benefits.” Substance misuse is a known barrier to employment, and while the reforms intend to move people into work, there’s no clear indication of increased investment in treatment to address this root cause. Existing funding for drug and alcohol services (e.g., £266.7 million for 2024/25) predates this statement and isn’t scaled up to match potential new demand from welfare changes.

On the flip side, the lack of direct cuts to treatment funding means services should, in theory, continue at current levels. The DHSC’s ongoing commitment to the Drug Strategy, including inpatient detoxification and recovery support, remains intact based on prior announcements. However, critics—like charities such as Disability Rights UK and Scope—warn that welfare reductions could push vulnerable groups, including those with substance misuse issues, into deeper poverty, potentially increasing alcohol and drug-related harm without corresponding treatment enhancements.

In short, the welfare adjustments don’t explicitly alter alcohol or drug treatment funding, but they could amplify demand for these services by reducing financial support for at-risk populations. Without new investment to match this pressure, the system might face challenges in meeting needs effectively. The real-world impact will depend on how local authorities adapt their public health budgets and whether future policy (e.g., the forthcoming Green Paper on health and disability benefits) addresses substance misuse more directly. For now, the connection is indirect but plausible, rooted in the socioeconomic ripple effects of welfare reform rather than a targeted policy shift.